Breast Cancer Clinical Trials in Baltimore

Showing 441-460 of 805 trials

Cardiac MRI Biomarker Testing (GCC 1618)

NCT02688166

This research study can help understand how cardiac changes may occur with radiation therapy to the heart based off measurements obtained through biomarkers and cardiac imaging. Researchers plan to perform cardiac imaging and biomarkers for any cardiac injury. Cardiac magnetic resonance imaging (CMR) provides the ability to quantitatively measure cardiac function and injury. The cardiac biomarkers that will be tested are effective in the diagnosis, risk-stratification, and monitoring of heart failure.

Breast CancerLung Cancer (Non-Small Cell)Thoracic Cancer+2 more

University of Maryland, Baltimore6 participantsStarted Feb 2018

Baltimore, Maryland, United States

COMPLETEDPhase 3< 1 mile

Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer

NCT00087178

RATIONALE: Drugs used in chemotherapy, such as fluorouracil, epirubicin, cyclophosphamide, and doxorubicin, work in different ways to stop tumor cells from dividing so they stop growing or die. It is not yet known which combination chemotherapy regimen is more effective in treating breast cancer. PURPOSE: This randomized phase III trial is studying two combination chemotherapy regimens to compare how well they work in treating women who have undergone surgery for breast cancer that has not spread to the lymph nodes.

Breast Cancer

NSABP Foundation Inc2,722 participantsStarted May 2004

Huntsville, Alabama, United States • Anchorage, Alaska, United States • Glendale, Arizona, United States +603 more locations

Cardiac MRI Biomarker Testing (GCC 1618)

Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer

Breast Cancer Trials in Other Cities

Phase I/II Study of PDR001 in Patients With Advanced Malignancies

A Study of Atezolizumab in Combination With Nab-Paclitaxel Compared With Placebo With Nab-Paclitaxel for Participants With Previously Untreated Metastatic Triple-Negative Breast Cancer (IMpassion130)

An Expanded Access Study to Provide at Home Subcutaneous Administration of Pertuzumab and Trastuzumab Fixed-Dose Combination (PH FDC SC) for Patients With HER2-Positive Breast Cancer During the COVID-19 Pandemic

1303GCC: Trastuzmab & Pertuzumab With Hormonal Therapy or Chemotherapy in Women Aged 60 and Over.

Radiation Therapy With or Without Optional Tamoxifen in Treating Women With Ductal Carcinoma in Situ

19F Hot Spot MRI of Human Adipose-derived Stem Cells for Breast Reconstruction

Ad/HER2/Neu Dendritic Cell Cancer Vaccine Testing

ONC201 in Recurrent/Refractory Metastatic Breast Cancer and Advanced Endometrial Carcinoma

Orteronel as Monotherapy in Patients With Metastatic Breast Cancer (MBC) That Expresses the Androgen Receptor (AR)

Bicalutamide in Treating Patients With Metastatic Breast Cancer

Assessing the Sensitivity of "SureTouch™" in Women Undergoing Diagnostic and Screening Mammography

EndoPredict® Extended Endocrine Trial (EXET)

A Study To Assess The Tolerability And Clinical Activity Of Gedatolisib In Combination With Palbociclib/Letrozole Or Palbociclib/Fulvestrant In Women With Metastatic Breast Cancer

A Study of Taselisib + Fulvestrant Versus Placebo + Fulvestrant in Participants With Advanced or Metastatic Breast Cancer Who Have Disease Recurrence or Progression During or After Aromatase Inhibitor Therapy

A Double-blind Study of Paclitaxel in Combination With Reparixin or Placebo for Metastatic Triple-Negative Breast Cancer

Stereotactic Radiation Therapy With or Without Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases

A Phase 1 Study to Evaluate MEDI4736 in Combination With Tremelimumab

Registrational Trial to Compare Effectiveness of Two Digital Software Medical Devices as Adjunctive Oncology Treatment

Other Conditions in Baltimore